Four People Treated After 46 Batteries Leaking Acid In Basement Of Engineering Department.
Oxford: Ebola Vaccine Trial Begins
A healthy Briton is to become the first person to receive a potential new vaccine for the Ebola virus.
The UK volunteer will be given the candidate inoculation in a safety trial being conducted by experts at the University of Oxford.
The person will be the first of 60 to receive the experimental drug in the UK trial.
The testing is part of a series of safety trials of potential vaccines to combat the virus, which could offer hope to the thousands facing the illness in West Africa where an outbreak has killed around 53% of those infected.
The vaccine, co-developed by the US National Institutes of Health and British drug company GlaxoSmithKline (GSK), targets the "Zaire species" of Ebola which is one of the strains circulating in West Africa.
It uses a single benign Ebola virus protein to generate an immune response. The university said the vaccine does not contain infectious Ebola virus material and will not cause a person taking part in the trial to be infected.
The trials are conducted on healthy people to see whether they suffer any side effects.
A man's been jailed for life for stabbing a father to death in the street in Oxford.
One in eight health bodies have higher-than-expected rates of stillbirths and neonatal death, a new report suggests.
Families in Oxfordshire are being sent letters warning that "cash-starved" schools must be given more funding
Recently Played Tracks
To listen live, choose your preferred station:
Now playing: The best feel good music
Deposit £10 to get a £40 Welcome Bonus - That's £50 to play bingo, slots and more!*
Over 50 tracks to make you feel-good. New album out now...
Find your local four day weather report here.